Clinical trials
Completed Peripheral Arterial Disease trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 11 |
| 2013 | 7 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 8 |
| 2017 | 10 |
| 2018 | 8 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| C. R. Bard | 8 |
| Cook Group Incorporated | 7 |
| Shockwave Medical, Inc. | 6 |
| Bayer | 5 |
| Spectranetics Corporation | 5 |
| Biotronik AG | 4 |
| Medtronic Endovascular | 4 |
| Universitätsklinikum Hamburg-Eppendorf | 4 |
| Cordis US Corp. | 3 |
| Flanders Medical Research Program | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 110 |
| Peripheral Vascular Diseases | 18 |
| Atherosclerosis | 15 |
| Intermittent Claudication | 14 |
| Chronic Limb-Threatening Ischemia | 10 |
| Cardiovascular Diseases | 7 |
| Vascular Diseases | 7 |
| Stroke | 5 |
| Coronary Artery Disease | 4 |
| Myocardial Infarction | 4 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.